Spatiotemporal Phosphoprotein Signaling in a Mouse Model Using Corticosterone and Relevant Organophosphates
Public Domain
-
2020/03/01
-
Details
-
Personal Author:
-
Description:Each year, 3 million people are exposed to organophosphates, contributing to approximately 300,000 deaths; many do not report appreciable acute effects immediately following exposure, but report symptoms of adverse neurological effects years later, as is the case for the 250,000 veterans from the 1991 Persian Gulf War who suffer from Gulf War Illness (GWI). Previous GWI research has focused on models that dose with acetylcholinesterase (AChE) inhibitors (chemical warfare agents and pesticides) and exogenous corticosterone (CORT), to simulate high stress, in efforts to mimic chronic neuroinflammation associated with GWI symptomology. An investigation into early phosphoprotein responses in the cortex and striatum were performed to better understand the similarities of the early cellular changes involved in these etiologies. Using a mouse model, adult male C57BL/6J mice were exposed to CORT in the drinking water for 7 days followed by a single injection of diisopropyl fluorophosphate (DFP; 4.0 mg/kg, i.p.) or chlorpyrifos oxon (CPO; 8.0 mg/kg, i.p.) on day 8 and euthanized 30 min, 2 h, and 24 h post-injection via focused microwave irradiation. To evaluate brain-region-specific effects, 20+ post-translationally modified protein targets were measured using a multiplex ELISA (e.g., ERK1/2, IkB-a, JNK, MEK1) for both dosing regimens. Several phosphoprotein responses (ZAP70 and JNK) were found to be significantly increased (p<0.05) for CORT+CPO exposure, but not for CORT+DFP in both brain regions. Conversely, CREB and ERK were significantly phosphorylated for DFP exposures relative to CPO. This suggests the neuroinflammatory response in this mouse model may be driven by off-target mechanisms of AChE exposure. Further investigation of other relevant exposures and their phosphoprotein signaling effects must be performed to better understand potential biomolecular drivers of GWI-like symptomology. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:1096-6080
-
Document Type:
-
Genre:
-
Place as Subject:
-
CIO:
-
Division:
-
Topic:
-
Location:
-
Volume:174
-
Issue:1
-
NIOSHTIC Number:nn:20058985
-
Citation:Toxicologist 2020 Mar; 174(1):485
-
CAS Registry Number:
-
Federal Fiscal Year:2020
-
Peer Reviewed:False
-
Source Full Name:The Toxicologist. Society of Toxicology 59th Annual Meeting and ToxExpo, March 15-19, 2020, Anaheim, California
-
Collection(s):
-
Main Document Checksum:urn:sha-512:5dbf4835032bbc299bc597a8147ff91a698ee8e8326da005d79bef4fa48835ecf04a46d26b7f0926f65757479c513ecee30e2cbdbef936a615219e0110fb746c
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like